SHA:600276 Market Cap

SHA:600276 has a market cap or net worth of 367.57 billion as of April 28, 2026. Its market cap has increased by 18.92% in one year.

Market Cap

367.57B

Enterprise Value

327.53B

Revenue

32.56B

Ranking

n/a

PE Ratio

45.27

Stock Price

54.84

Market Cap Chart

Since October 20, 2000, SHA:600276's market cap has increased from 2.58B to 367.57B, an increase of 14,166.00%. That is a compound annual growth rate of 21.44%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	367.57B	-7.12%
Dec 31, 2025	395.76B	35.60%
Dec 31, 2024	291.86B	1.48%
Dec 29, 2023	287.60B	17.03%
Dec 30, 2022	245.74B	-23.94%
Dec 31, 2021	323.08B	-45.40%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sichuan Biokin Pharmaceutical	117.27B
Zhejiang NHU Company	106.85B
Yunnan Baiyao Group Co.,Ltd	97.12B
Shanghai Fosun Pharmaceutical (Group)	62.77B
Shenzhen Salubris Pharmaceuticals	61.89B
Huadong Medicine	61.70B
China Resources Sanjiu Medical & Pharmaceutical	45.18B
Beijing Tongrentang	37.88B

Market Cap Rankings